Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
ACS Chemical Neuroscience
|
August 12, 2025
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors
Gabriele Carullo, Ilaria Piano, Giulia Salamone, et al.
Bioorganic Chemistry
|
June 26, 2026
Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A<sub>2A</sub> adenosine receptor antagonists in neuroinflammatory diseases
Sara Calenda, Katarina Mihajlovic, Flavia Varano, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients
Anna Fontana, Laura Bergantini, Gabriele Carullo, et al.
ACS Pharmacology & Translational Science
|
July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
Bioorganic Chemistry
|
October 18, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells
Ilaria Cursaro, Luca Frattaruolo, Laura Scalvini, et al.
Journal of Medicinal Chemistry
|
July 4, 2024
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy
Gabriele Carullo, Noemi Orsini, Ilaria Piano, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
ACS Chemical Neuroscience
|
August 12, 2025
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors
Gabriele Carullo, Ilaria Piano, Giulia Salamone, et al.
Bioorganic Chemistry
|
June 26, 2026
Design, synthesis, and pharmacological evaluation of thiazolo[5,4-d]pyrimidines hybridized with lipoic acid or catechol. Novel A<sub>2A</sub> adenosine receptor antagonists in neuroinflammatory diseases
Sara Calenda, Katarina Mihajlovic, Flavia Varano, et al.
ACS Pharmacology & Translational Science
|
February 20, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients
Anna Fontana, Laura Bergantini, Gabriele Carullo, et al.
ACS Pharmacology & Translational Science
|
July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
Bioorganic Chemistry
|
October 18, 2025
New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells
Ilaria Cursaro, Luca Frattaruolo, Laura Scalvini, et al.
Journal of Medicinal Chemistry
|
July 4, 2024
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy
Gabriele Carullo, Noemi Orsini, Ilaria Piano, et al.
Page
of 2